#Israel #Tel Aviv #Varana Capital #Stämm #SuperMeat

Stämm and SuperMeat: A Groundbreaking Collaboration in Cultivated Meat Production

In an exciting intersection of technology and food production, Stämm has announced a collaboration with SuperMeat to push the boundaries of cultivated meat manufacturing. With the backing of their mutual investor Varana Capital, this partnership aims to capitalize on Stämm’s unique bioreactor technology to enhance SuperMeat’s cultivated chicken processes.

The Partnership

This joint venture's main goal is to integrate Stämm’s cutting-edge Bioprocessor into SuperMeat’s production framework, leveraging advanced techniques that have previously shown success in pharmaceutical applications. The results from their initial trials are promising, and the two companies are anticipating a transformative impact on the cultivated meat industry.

SuperMeat stands out as a pioneer in the cultivated meat space, especially after recently achieving a significant milestone: producing cultivated chicken at a cost of just $11.79 per pound. This breakthrough allows for a faster, higher yield of muscle and fat directly from animal cells, streamlining the production process. Stämm’s Bioprocessor aims to complement and enhance these efficiencies, potentially revolutionizing the way cultivated meat is produced.

Integrating Technologies

Yuyo Llamazares Vegh, CEO of Stämm, has expressed enthusiasm about the potential of this collaboration: “In the coming months, a joint team will benchmark and evaluate how to integrate our Bioprocessor into SuperMeat's end-to-end production process. We are excited to see the results of this unique alliance.”

The two companies are focusing on enhancing various key aspects of meat production, including muscle fiber growth, elongation, and the formation of mature muscle tissue, as well as improving adipocyte formation. The goal is to produce organic whole-cut pieces of cultivated meat that closely resemble traditional meat structures, both in appearance and flavor, thus expanding consumer appeal.

Ido Savir, CEO of SuperMeat, highlights the significance of the partnership by stating: “This partnership demonstrates how complementary technologies can combine to drive progress in the cultivated meat industry. By uniting our technologies, we create a pathway to whole cut cultivated meat products that deliver superior quality and consumer appeal.”

A Bright Future for Cultivated Meat

The collaboration not only aims for technological advancements but is also looking into developing a scalable process model that could lower production costs substantially through increased efficiency in culture media utilized for biomass production. As the alternative protein market is predicted to soar to a staggering $290 billion by 2035, this partnership is entering a promising landscape ripe with opportunity.

Ezra Gardner, Co-Founder and CIO of Varana Capital, asserts the strategic significance of this initiative: “Israel's exceptional entrepreneurial spirit and technological prowess make it an ideal investment destination for advancing the revolution in alternative protein production. We are excited to introduce Stamm's biomanufacturing innovation into this ecosystem.”

Conclusion

With an increasing number of consumers seeking sustainable and ethical food options, the collaboration between Stämm and SuperMeat could not come at a better time. As they work towards scaling up cultivated meat production while reducing costs and enhancing the quality of their products, they may well set the stage for a new era in the food industry. This partnership represents not only a marriage of advanced technologies but also a vision for a future where cultivated meat could become a staple in diets worldwide.